Candida Summit

Alzheimers and Dementia Summit

Friday, February 3, 2017

The Truth About Vaccines (TTAV) Docu-series (Affiliate Registrations Now Open

Some of these speakers were featured in the Vaccines Revealed docu-series.

Join us to share The Truth About Vaccines (coming in April):...

Register To Watch Free:
* Above link is not open yet; registrations will start in March.

Affiliate Opportunity:

From TTAV:

All of our promotions are filled with a mission and a powerful message, so the topic of Vaccines is no exception. In fact, the stakes are higher since there are kids lives on the line.

With all that said, there is a significant financial opportunity as an affiliate. Since we started in May, 2014, we’ve launched 6 super successful docu-series launches...reaching over 20 million visitors with over 2 million+ people opting in to watch the episodes.

We have had an overage opt-in rate of over 50% across the board and our affiliates have consistently earned an average of over $2+ per click.

Our affiliate partners have been paid more than $10 million dollars for sharing our events with their audiences through email, Facebook, Twitter, etc.

As an affiliate, you get to...

  • Provide your followers with free, super high quality content. You’ll never send a sales email to them for our promotion.
  • We’ll make it simple and easy for you. We send you extensive email and social media swipes that you can easily copy and paste or make slight tweaks to.
  • Confidence in our conversions since we’ve perfected this model over 3 years with more than $10 million dollars paid to our affiliates using this exact launch model.
  • Receive 100% of your commissions within 40 days from when the promotion ends.
  • Earn up to $60,000 dollars in cash affiliate contest prizes
  • Receive lifetime commissions for every sale from the clickers as well as the leads you send us
  • Help save babies' lives! Daily we receive personal letters/emails from people saying “I (or a loved one) am alive today because of your event.”



No comments: